GeneQuine Biotherapeutics

About:

GeneQuine Biotherapeutics develops gene therapy for the treatment of osteoarthritis

Website: http://www.genequine.com/de/

Top Investors: HTGF | High-Tech Gruenderfonds, IFB Innovationsstarter, Meusinvest (Noshaq), Pacira Pharmaceuticals, Investitionsbank des Landes Brandenburg

Description:

GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.

Total Funding Amount:

9.05M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hamburg, Hamburg, Germany

Founded Date:

2011-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2021-02-15

IPO Status:

Private

Industries: